Literature DB >> 30253064

Neuroinflammation Quantification for Spinal Cord Injury.

Jesús Amo-Aparicio1, Anna Martínez-Muriana1, Alba Sánchez-Fernández1, Rubèn López-Vales1.   

Abstract

Spinal cord injury (SCI) leads to irreversible devastating neurological disabilities. Accumulated evidence in the literature indicates that the inflammatory response that occurs in the spinal cord following injury contributes importantly to spread tissue damage to healthy regions adjacent to the lesion site, and consequently, to increase neurological deficits. Therefore, targeting inflammation could lead to the development of new therapies to prevent tissue damage and neurological impairments after SCI. Inflammation is regulated, in part, by the expression of pro-inflammatory and anti-inflammatory cytokines synthesized, mainly, by glial cells. Hence, methodologies that could ease the quantification of multiple cytokines and immune cells from spinal cord tissue samples are needed to assess the potential of new anti-inflammatory therapies. In the present unit, we describe how to induce contusion injuries in the mouse spinal cord, as well as, two useful methodologies to assess neuroinflammation in lesioned spinal cord tissue samples.
© 2018 by John Wiley & Sons, Inc. © 2018 John Wiley & Sons, Inc.

Entities:  

Keywords:  cytokines; immune cells; neuroinflammation; spinal cord injury

Mesh:

Year:  2018        PMID: 30253064     DOI: 10.1002/cpim.57

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  8 in total

Review 1.  Roles of Fatty Acids in Microglial Polarization: Evidence from In Vitro and In Vivo Studies on Neurodegenerative Diseases.

Authors:  Miey Park; Hae-Jeung Lee
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

2.  Identification of four genes and biological characteristics associated with acute spinal cord injury in rats integrated bioinformatics analysis.

Authors:  Qiang Li; Bo Li; Bo Tao; Chenxi Zhao; Baoyou Fan; Qi Wang; Chao Sun; Huiquan Duan; Yilin Pang; Xuanhao Fu; Shiqing Feng
Journal:  Ann Transl Med       Date:  2021-04

3.  OLT1177 (Dapansutrile), a Selective NLRP3 Inflammasome Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis.

Authors:  Alba Sánchez-Fernández; Damaris B Skouras; Charles A Dinarello; Rubèn López-Vales
Journal:  Front Immunol       Date:  2019-11-01       Impact factor: 7.561

4.  IL-37 exerts therapeutic effects in experimental autoimmune encephalomyelitis through the receptor complex IL-1R5/IL-1R8.

Authors:  Alba Sánchez-Fernández; Stephanie Zandee; Jesús Amo-Aparicio; Marc Charabati; Alexandre Prat; Cecilia Garlanda; Elan Z Eisenmesser; Charles A Dinarello; Rubèn López-Vales
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

5.  TAT-modified serum albumin nanoparticles for sustained-release of tetramethylpyrazine and improved targeting to spinal cord injury.

Authors:  Yan Lin; Yujie Wan; Xingjie Du; Jian Li; Jun Wei; Ting Li; Chunhong Li; Zhongbing Liu; Meiling Zhou; Zhirong Zhong
Journal:  J Nanobiotechnology       Date:  2021-01-21       Impact factor: 10.435

6.  Interleukin-4 and interleukin-13 induce different metabolic profiles in microglia and macrophages that relate with divergent outcomes after spinal cord injury.

Authors:  Jesus Amo-Aparicio; Joana Garcia-Garcia; Isaac Francos-Quijorna; Andrea Urpi; Anna Esteve-Codina; Marta Gut; Albert Quintana; Ruben Lopez-Vales
Journal:  Theranostics       Date:  2021-10-03       Impact factor: 11.556

7.  Extracellular and nuclear roles of IL-37 after spinal cord injury.

Authors:  Jesus Amo-Aparicio; Alba Sanchez-Fernandez; Suzhao Li; Elan Z Eisenmesser; Cecilia Garlanda; Charles A Dinarello; Ruben Lopez-Vales
Journal:  Brain Behav Immun       Date:  2020-09-28       Impact factor: 7.217

8.  Administration of Maresin-1 ameliorates the physiopathology of experimental autoimmune encephalomyelitis.

Authors:  Alba Sánchez-Fernández; Stephanie Zandee; Mauricio Mastrogiovanni; Marc Charabati; Homero Rubbo; Alexandre Prat; Rubèn López-Vales
Journal:  J Neuroinflammation       Date:  2022-02-02       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.